A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
Clinical trial NCT03192969 · WITHDRAWN
Trial details
- NCT number
- NCT03192969
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-15
- Primary completion
- 2020-06-07
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.